DelveInsight Business Research LLP

DelveInsight’s ‘Ankylosing Spondylitis – Market Insights, Epidemiology, and Market Forecast–2032’ report delivers an in-depth understanding of the AS, historical and forecasted epidemiology as well as the Ankylosing Spondylitis market trends in the United States, , EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.

Ankylosing Spondylitis Overview

Ankylosing Spondylitis also called as Bechterew’s disease is a common inflammatory rheumatic disease that affects the axial skeleton, causing characteristic inflammatory back pain, which can lead to structural and functional impairments and a decrease in quality of life. Clinical features of this group include inflammatory back pain, asymmetrical peripheral oligoarthritis (predominantly of the lower limbs), enthesitis, and specific organ involvement such as anterior uveitis, psoriasis, and chronic inflammatory bowel disease. Aortic root involvement and conduction abnormalities are rare complications of AS. AS affects men more often than women. 

Some of the key facts of Ankylosing Spondylitis Market Report:

The general onset of Ankylosing Spondylitis commonly occurs in younger people, between the ages of 17 and 45. However, it can also affect children and those who are much older.

Ankylosing Spondylitis Epidemiological Segmentation 

• Ankylosing Spondylitis (Bekhterevs Disease) prevalent cases 

• Ankylosing Spondylitis (Bekhterevs Disease) incident cases

• Ankylosing Spondylitis (Bekhterevs Disease) diagnosed cases 

• Ankylosing Spondylitis (Bekhterevs Disease) treatment cases 

Got queries? Click here to learn more about the  Ankylosing Spondylitis Market Landscape 

Ankylosing Spondylitis Market Outlook 

Ankylosing spondylitis is an inflammatory disease that, over time, can cause some of the small bones in the spine (vertebrae) to fuse. This fusing makes the spine less flexible and can result in a hunched-forward posture. If ribs are affected, it can be difficult to breathe deeply. There is no cure for Ankylosing Spondylitis, but treatments can lessen your symptoms and possibly slow the progression of the disease.  

A common treatment regimen for the various forms of spondyloarthritis involves medication, exercise, physical therapy, good posture practices, and other options such as applying heat/cold to help relax muscles and reduce joint pain. In severe cases, posture-correcting surgery may also be an option.

Ankylosing Spondylitis Market Key Companies working on it 

• UCB

• AbbVie

• Pfizer

• Astella

• Amgen

• Novartis

• Iroko Pharmaceuticals

• Syntex Pharmaceuticals

And many others 

Ankylosing Spondylitis Market Key Therapies Covered and Analyzed in the Report:

• Bimekizumab

• CC-99677

• Adalimumab

• Infliximab

• Etanercept

• Sarilumab

• Secukinumab

• GP2017

And many others 

Learn more about the Ankylosing Spondylitis Key Companies

Table of Contents

1. Key Insights 

2. Report Introduction 

3. Executive Summary of Ankylosing Spondylitis Epilepsy Market 

4. Ankylosing Spondylitis  Epilepsy Disease Background and Overview

5. Ankylosing Spondylitis Epilepsy Epidemiology and patient population

6. Ankylosing Spondylitis Epilepsy Market Emerging Therapies

7. Ankylosing Spondylitis Epilepsy Market Cancer Market Outlook

8. Market Access and Reimbursement of Therapies

9. Appendix

10. Ankylosing Spondylitis Epilepsy Market Report Methodology

11. DelveInsight Capabilities

12. Disclaimer

13. About DelveInsight

Learn more about the detailed offerings of the report:  Ankylosing Spondylitis (Bekhterevs Disease) Epilepsy Market Outlook

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Adya Kaul
Email: Send Email
Phone: 919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services